Henry Ford Health System Launches Tough Love Campaign Saturday, December 5, 2020

December 4, 2020

Henry Ford Health System is mounting a multi-media, multi-platform effort to encourage Michiganders to show their toughness and compassion through a renewed commitment to protecting those we love.

Henry Ford Health System advises the “Tough Love” campaign will launch publicly across TV and social media on Saturday, December 5, and later on radio and in print, acknowledging that, while it is not tough to wear a mask, wash your hands, or practice social distancing. “It’s tough as nails to keep at it…months after we thought this thing would be behind us,” to cancel holiday plans or to show your family and friends how much you love them by NOT seeing them.

View video here.

“It’s one thing to talk about infection and death rates, and repeating that people should wear masks, keep washing their hands and continue social distancing,” said Heather Geisler, Henry Ford SVP and Chief Marketing, Communications and Experience Officer. “It’s quite another to demonstrate in the starkest terms how we have endured and overcome past challenges as a community, and how we can be tough enough to get to the other side of this one. These individual acts of resolve will make all the difference.”

Using archival images of other tough situations faced by Michiganders, including civil unrest in the 1960s, monstrous snowstorms, as well as the determined and dedicated faces of Henry Ford frontline healthcare workers, the campaign calls on people to be tough and to persevere for the love of their neighbors, family and friends so that we can all celebrate the holidays next year “with no more empty chairs around the table.”

In addition to radio, TV, print and social media, and Tough Love webpage, the campaign will also include other non-traditional efforts, including “Tough Love Letters” –  an ongoing collection of select letters and notes from our frontline workers about the toughness they face on the front lines of the pandemic every day.

“At its core, this campaign acknowledges the fatigue we all feel and encourages perseverance, but it’s also a love letter to our team members and those who are struggling,” said Geisler. “We have been so inspired by the grit and compassion we’ve seen in our organization and our communities and we want to honor that.”

The campaign comes on the heels of a mask advocacy campaign, launched last week by Henry Ford and HAP, to distribute more than 260,000 masks to employees, community groups, seniors, and corporate health partners. HAP is also distributing masks to members of its Medicare and Medicaid plans.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”